These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24920438)

  • 1. The sHunt for better breathing in heart failure with preserved ejection fraction.
    Borlaug BA
    Eur J Heart Fail; 2014 Jul; 16(7):709-11. PubMed ID: 24920438
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure.
    Søndergaard L; Reddy V; Kaye D; Malek F; Walton A; Mates M; Franzen O; Neuzil P; Ihlemann N; Gustafsson F
    Eur J Heart Fail; 2014 Jul; 16(7):796-801. PubMed ID: 24961390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial.
    Hasenfuss G; Gustafsson F; Kaye D; Shah SJ; Burkhoff D; Reymond MC; Komtebedde J; Hünlich M;
    J Card Fail; 2015 Jul; 21(7):594-600. PubMed ID: 26055211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection Fraction.
    Kaye DM; Hasenfuß G; Neuzil P; Post MC; Doughty R; Trochu JN; Kolodziej A; Westenfeld R; Penicka M; Rosenberg M; Walton A; Muller D; Walters D; Hausleiter J; Raake P; Petrie MC; Bergmann M; Jondeau G; Feldman T; Veldhuisen DJ; Ponikowski P; Silvestry FE; Burkhoff D; Hayward C
    Circ Heart Fail; 2016 Dec; 9(12):e003662. PubMed ID: 27852653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. InterAtrial Shunt Device (IASD®) implantation - a novel treatment method for heart failure with preserved ejection fraction.
    Kosowski M; Kübler P; Kołodziej A; Krakowiak B; Kustrzycka-Kratochwil D; Sławin J; Sokolski M; Biegus J; Zymliński R; Banasiak W; Ponikowski P; Reczuch K
    Kardiol Pol; 2017; 75(8):736-741. PubMed ID: 28541594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I).
    Feldman T; Komtebedde J; Burkhoff D; Massaro J; Maurer MS; Leon MB; Kaye D; Silvestry FE; Cleland JG; Kitzman D; Kubo SH; Van Veldhuisen DJ; Kleber F; Trochu JN; Auricchio A; Gustafsson F; Hasenfuβ G; Ponikowski P; Filippatos G; Mauri L; Shah SJ
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27330010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction.
    Nanayakkara S; Kaye DM
    Heart Fail Rev; 2023 Mar; 28(2):281-286. PubMed ID: 35438418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [InterAtrial Shunt Device in diastolic heart failure].
    Hasenfuß G; Jacobshagen C
    Internist (Berl); 2018 Oct; 59(10):1054-1062. PubMed ID: 30194481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Atrial Decompression Using Unidirectional Left-to-Right Interatrial Shunt: Initial Experience in Treating Symptomatic Heart Failure With Preserved Ejection Fraction With the W-Wave Device.
    Amat-Santos IJ; Del Trigo M; Bergeron S; Pibarot P; Altisent O; Campelo-Parada F; Puri R; Verheye S; Keren G; Katzenellenbogen R; Rozenfeld E; Abraham WT; Bernier M; Rodés-Cabau J
    JACC Cardiovasc Interv; 2015 May; 8(6):870-872. PubMed ID: 25999114
    [No Abstract]   [Full Text] [Related]  

  • 10. Symptomatic pulmonary hypertension with giant left atrial v waves after surgical maze procedures: evaluation by comprehensive hemodynamic catheterization.
    Welch TD; Coylewright M; Powell BD; Asirvatham SJ; Gersh BJ; Dearani JA; Nishimura RA
    Heart Rhythm; 2013 Dec; 10(12):1839-42. PubMed ID: 24050987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous transhepatic stenting of a restrictive atrial septal communication in hypoplastic left heart syndrome.
    Al Senaidi K; Al Mesned A; Coe JY
    Catheter Cardiovasc Interv; 2014 Jun; 83(7):E269-71. PubMed ID: 24532371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creation of a restrictive atrial left-to-right shunt: a novel treatment for heart failure.
    De Rosa R; Schranz D
    Heart Fail Rev; 2018 Nov; 23(6):841-847. PubMed ID: 30267205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microprobe transoesophageal echocardiographic guidance during transcatheter interatrial septal device implantation in heart failure with a preserved ejection fraction.
    Snijder RJ; Swaans MJ; van der Heyden JA; Post MC
    EuroIntervention; 2016 Jun; 12(3):401. PubMed ID: 27320431
    [No Abstract]   [Full Text] [Related]  

  • 14. Creation of a restrictive atrial communication in heart failure with preserved and mid-range ejection fraction: effective palliation of left atrial hypertension and pulmonary congestion.
    Bauer A; Khalil M; Lüdemann M; Bauer J; Esmaeili A; De-Rosa R; Voelkel NF; Akintuerk H; Schranz D
    Clin Res Cardiol; 2018 Sep; 107(9):845-857. PubMed ID: 29663123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel implant.
    Malek F; Neuzil P; Gustafsson F; Kaye DM; Walton A; Mates M; Søndergaard L; Ihlemann N; Mariani JA; Reddy V
    Int J Cardiol; 2015; 187():227-8. PubMed ID: 25841123
    [No Abstract]   [Full Text] [Related]  

  • 16. [Assessment of left atrial phasic functions in heart failure patients with preserved or low ejection fractions].
    Bilen E; Kurt M; Tanboğa IH; Koçak U; Ayhan H; Durmaz T; Bozkurt E
    Turk Kardiyol Dern Ars; 2012 Mar; 40(2):122-8. PubMed ID: 22710583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The atrial flow regulator: current overview on technique and first experience.
    Paitazoglou C; Bergmann MW
    Ther Adv Cardiovasc Dis; 2020; 14():1753944720919577. PubMed ID: 32972299
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction.
    Melenovsky V; Borlaug BA; Rosen B; Hay I; Ferruci L; Morell CH; Lakatta EG; Najjar SS; Kass DA
    J Am Coll Cardiol; 2007 Jan; 49(2):198-207. PubMed ID: 17222731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial.
    Hasenfuß G; Hayward C; Burkhoff D; Silvestry FE; McKenzie S; Gustafsson F; Malek F; Van der Heyden J; Lang I; Petrie MC; Cleland JG; Leon M; Kaye DM;
    Lancet; 2016 Mar; 387(10025):1298-304. PubMed ID: 27025436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.
    Melenovsky V; Hwang SJ; Redfield MM; Zakeri R; Lin G; Borlaug BA
    Circ Heart Fail; 2015 Mar; 8(2):295-303. PubMed ID: 25593126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.